Simeng Suy Selected Research

Simeng Suy Research Topics

Disease

66	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2009
18	Neoplasms (Cancer) 01/2022 - 03/2005
7	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2012
5	Carcinoma (Carcinomatosis) 01/2020 - 03/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2012
3	Hemorrhage 01/2021 - 11/2016
3	Proctitis 01/2020 - 12/2014
2	Carcinogenesis 01/2022 - 11/2021
2	Telangiectasis (Telangiectasia) 01/2021 - 01/2017
2	Hematuria 01/2021 - 02/2015
2	Inflammation (Inflammations) 01/2017 - 12/2010
2	Fatigue 01/2017 - 01/2012
2	Adenocarcinoma 01/2014 - 12/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014 - 03/2013
1	Obesity 01/2022
1	Ejaculatory Dysfunction 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Hemospermia 01/2021
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2021
1	Hyperemia 01/2020
1	Atrial Fibrillation 01/2020
1	Uterine Neoplasms (Uterine Cancer) 01/2020
1	Varicose Veins (Varicose Vein) 01/2020
1	Cutaneous Fistula 01/2020
1	Pathologic Processes 01/2019
1	Lower Urinary Tract Symptoms 06/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Starvation 10/2015
1	Dysuria 01/2015
1	Urinary Retention 07/2014
1	Urinary Incontinence 06/2014
1	Nocturia 01/2014
1	Erectile Dysfunction 11/2013
1	Headache (Headaches) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2011
1	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2011
1	Hyperplasia 12/2010
1	Atrophy 12/2010
1	Glioma (Gliomas) 06/2010

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2011
7	Hormones (Hormone)IBA 01/2022 - 03/2005
7	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 12/2010
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
6	AndrogensIBA 01/2020 - 04/2009
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2021 - 01/2019
2	AnticoagulantsIBA 01/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 06/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2011
2	Oxygen (Dioxygen)IBA 01/2017 - 01/2005
2	Gemcitabine FDA Link 01/2014 - 03/2013
2	Voltage-Gated Sodium ChannelsIBA 11/2012 - 03/2012
2	Protein Isoforms (Isoforms)IBA 11/2012 - 03/2012
2	GoldIBA 01/2012 - 02/2010
2	Testosterone (Sustanon)FDA Link 01/2012 - 03/2011
1	HydrogelsIBA 01/2022
1	LeptinIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Jagged-1 ProteinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	5-alpha Reductase InhibitorsIBA 01/2021
1	RivaroxabanIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 06/2018
1	CytokinesIBA 01/2017
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2016
1	Sirtuin 1IBA 10/2015
1	SteroidsIBA 01/2013
1	Caspase 7IBA 01/2012
1	Bronchodilator Agents (Bronchodilators)IBA 01/2012
1	plastochromanol 8IBA 01/2012
1	TocotrienolsIBA 01/2012
1	Biological ProductsIBA 05/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	EnzymesIBA 01/2011
1	Myosin-Light-Chain PhosphataseIBA 01/2011
1	Circulating MicroRNAIBA 01/2011
1	Radiation-Sensitizing AgentsIBA 10/2010
1	Temozolomide (Temodar)FDA LinkGeneric 06/2010
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2010
1	Small Interfering RNA (siRNA)IBA 04/2009
1	AMP-Activated Protein KinasesIBA 04/2009
1	dorsomorphinIBA 04/2009

Therapy/Procedure

63	Radiotherapy 01/2022 - 01/2005
10	Therapeutics 01/2021 - 01/2011
8	Aftercare (After-Treatment) 01/2021 - 10/2010
6	Brachytherapy 10/2020 - 01/2013
2	Contraindications 01/2020 - 01/2015
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2018 - 08/2015
1	Treatment Delay 01/2021
1	Cautery 01/2021
1	Cryotherapy (Therapy, Cold) 01/2020
1	Transurethral Resection of Prostate (TURP) 01/2020
1	Drug Tapering 01/2016
1	Metastasectomy 01/2012
1	Castration 01/2011
1	Palliative Care (Palliative Therapy) 10/2010
1	Image-Guided Radiotherapy 06/2010
1	Chemoprevention 04/2009